NFKB1 and metabolic dysfunction-associated steatotic liver disease: We showed that circRNA_0001805 exerts protective effects in NAFLD cellular and animal models by modulating the NF-κB signaling axis via miR-106a-5p, miR-320a/ABCA1 and CPT1.